PRODH and breast carcinoma: Relevant to inhibitor discovery, the noncovalent PRODH inhibitor S-(-)-tetrahydro-2-furoic acid (THFA) was shown to inhibit the spheroidal growth of breast cancer cells and impair the formation of lung metastases in mouse models of breast cancer [7].